Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.88 HKD | +1.33% | -3.78% | +2.99% |
Apr. 15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
Apr. 15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
OCUMENSION THERAPEUTICS | Other Pharmaceuticals | +1.33% | -3.78% | +2.99% | -15.89% | - | 603M |
- Stock Market
- Equities
- 1477 Stock
- Charts Ocumension Therapeutics
- Relative Strength Chart